NCT04760483View on ClinicalTrials.gov

Office Based Transperineal Laser Ablation for Benign Prostatic Hyperplasia HYPERPLASIA

PHASE1Active, not recruitingINTERVENTIONAL
Enrollment

20

Participants

Timeline

Start Date

November 20, 2020

Primary Completion Date

March 19, 2022

Study Completion Date

March 20, 2026

Conditions
Male Urogenital DiseasesGenital Diseases, MaleProstatic DiseaseProstatic Hyperplasia
Interventions
DEVICE

SoracteLite(TM) TPLA for BPH

see prior section

Trial Locations (1)

33016

Urology Specialist Group, Hialeah

All Listed Sponsors
lead

Urological Research Network, LLC

OTHER

NCT04760483 - Office Based Transperineal Laser Ablation for Benign Prostatic Hyperplasia HYPERPLASIA | Biotech Hunter | Biotech Hunter